AstraZeneca’s Ambitious US $50 Billion Investment Plan Targets Growth Amid Global Economic Shifts

In a decisive step to enhance its presence and operations in the United States, AstraZeneca, the renowned British-Swedish pharmaceutical giant, has announced a substantial $50 billion investment by 2030. This strategic move comes amidst a backdrop of global economic shifts,…